Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer

Ubiquitin-specific protease 22 (USP22), a novel ubiquitin hydrolase, has been implicated in oncogenesis and cancer progression in various types of human cancer. However, the clinical significance of USP22 expression in non-small cell lung cancer (NSCLC) has not been determined. In the present study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, J., Zhang, J., Liu, W., Lang, Y., Xue, Y., Xu, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2012
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567765/
https://www.ncbi.nlm.nih.gov/pubmed/23361242
http://dx.doi.org/10.4081/ejh.2012.e46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567765/
https://www.ncbi.nlm.nih.gov/pubmed/23361242
http://dx.doi.org/10.4081/ejh.2012.e46

Ejemplares similares